Terns Pharmaceuticals
TERN
TERN
78 hedge funds and large institutions have $630M invested in Terns Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 26 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
20% more funds holding
Funds holding: 65 → 78 (+13)
9.78% less ownership
Funds ownership: 103.68% → 93.9% (-9.8%)
Holders
78
Holding in Top 10
7
Calls
–
Puts
–
Top Buyers
| 1 | +$23.6M | |
| 2 | +$16M | |
| 3 | +$8.38M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$6.8M |
| 5 |
BlackRock
New York
|
+$4.75M |
Top Sellers
| 1 | -$10.2M | |
| 2 | -$9.38M | |
| 3 | -$6.81M | |
| 4 |
PVI
Pura Vida Investments
New York
|
-$6.16M |
| 5 |
AC
Armistice Capital
New York
|
-$5.7M |